Physician
Nelken, Beata
Nelken, Beata was paid $4.17M by Medicaid between Jan 2018 and Dec 2024, across 54 billing codes. Its largest line is 0241U, Neonatal screening for hereditary disorders, genomic sequence analysis panel — 21% of everything it billed.
33Billing provider infoNELKEN, BEATA
WOONSOCKET, RI 02895
WOONSOCKET, RI 02895
33aNPI1518922095assigned 04/19/2006
33bProvider typePediatrics Physician
28Total paid$4.17M
24GClaims81,162
24DCodes billed54
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Rhode Island
Rank by total paid#2 of 265
Median peer was paid$133K
This provider vs. median31×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 180 | $4K | |
| 2019 | 148 | $3K | |
| 2020 | 21,678 | $1.05M | |
| 2021 | 23,889 | $1.04M | |
| 2022 | 17,275 | $975K | |
| 2023 | 11,571 | $712K | |
| 2024incomplete | 6,421 | $383K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 21% | 6,698 | 6,124 | $887K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 7,815 | 5,165 | $560K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 11% | 7,488 | 5,191 | $450K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 10% | 10,838 | 8,044 | $428K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 8.6% | 10,013 | 6,690 | $359K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.4% | 1,896 | 1,123 | $183K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.8% | 3,190 | 1,344 | $158K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.4% | 1,489 | 1,191 | $140K |
| 92587 | 3.2% | 2,569 | 1,861 | $135K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.8% | 1,302 | 1,001 | $115K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.3% | 990 | 957 | $96K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.8% | 787 | 339 | $77K |
42 more codes
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.6% | 1,398 | $68K |
| 90461 | 1.4% | 1,815 | $59K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.2% | 1,654 | $50K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.2% | 1,826 | $49K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.1% | 3,490 | $44K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.0% | 403 | $43K |
| 97802 | <1% | 1,671 | $31K | |
| 99050 | <1% | 697 | $30K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,342 | $30K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 1,233 | $25K |
| 0012A | <1% | 611 | $20K | |
| 87428 | <1% | 298 | $17K | |
| 0011A | <1% | 620 | $15K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 956 | $14K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 607 | $14K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 84 | $11K |
| 3725F | <1% | 597 | $11K | |
| 0003A | <1% | 268 | $10K | |
| 0013A | <1% | 254 | $10K | |
| 99177 | <1% | 1,765 | $9K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 44 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 356 | $4K |
| 96127 | <1% | 1,030 | $3K | |
| 0002A | <1% | 115 | $3K | |
| 0001A | <1% | 78 | $2K | |
| 99383 | <1% | 19 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 123 | $1K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 13 | $650.00 |
| 0064A | <1% | 17 | $641.61 | |
| 90474 | <1% | 58 | $546.93 | |
| 0124A | <1% | 12 | $512.16 | |
| 0154A | <1% | 13 | $426.80 | |
| 99072 | <1% | 29 | $172.50 | |
| 96160 | <1% | 44 | $167.70 | |
| 94760 | <1% | 57 | $134.78 | |
| 96161 | <1% | 29 | $116.41 | |
| 90686 | <1% | 244 | $98.25 | |
| 99173 | <1% | 92 | $85.96 | |
| 90633 | <1% | 67 | $11.00 | |
| 90716 | <1% | 14 | $1.00 | |
| 91307 | 0% | 13 | $0.00 | |
| 91301 | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.